PODD

Insulet Corporation
Data: 2026-01-30
$255.81
Price
0.38%
Change
$354.88
52W High
$230.05
52W Low

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Quick Stats
Jan 30, 2026

53.5

AI Score

HOLD

1.61

Volume Ratio

Feb 18, 2026

Next Earnings

13

+ve Days (30d)

17

-ve Days (30d)

PODD Stock Summary

Last updated Jan 30, 2026

PODD is currently trading at $255.81, positioned below its 200-day moving average of $304.91, suggesting bearish momentum. The stock has a 52-week range of $230.05 to $354.88.

Technical Analysis: The 50-day moving average stands at $294.46, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 26.289, suggesting the stock is oversold and potentially undervalued.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.117, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates PODD at 53.5/100 with a HOLD recommendation.

PODD (Insulet Corporation) Indicators

Last updated Jan 30, 2026

Indicator Value
RSI(14) 26.289
CMF (20) -0.117
ROC (10) -10.709
ADX (14) 44.136
Indicator Value
MACD (12,26,9) -9.522
AROONOSC (14) -100.0
WILLAMS %R (14) -92.351
MFI (14) 30.9
PODD Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

PODD Price vs Max Options Open Interest
PODD Max Change In Options Open Interest

PODD Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

PODD Daily Out of Money Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

PODD Daily In the Money Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

PODD Most Active Options by Volume(near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Insulet Corporation is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

PODD Moving Averages Analysis

PODD (Insulet Corporation) Simple Moving Averages

Moving Averages are last updated Jan 30, 2026

Days MA
10 271.4
20 279.1
30 282.19
50 294.46
100 308.8
200 304.91

PODD Fundamental Analysis

P/E (Forward) 41.841
P/E (Trailing) 74.7982
Market Cap ($) 18.0 billion
Earnings/Share ($) 3.42
Net Proft Margin (%) 0.0976
Dividend/Share ($) --
EPS Estimate Current Year ($) 4.8935
EPS Estimate Next Year ($) 6.1806
WallStreet Target Price ($) 370.44
Most Recent Quarter